Latest News about NVCR
Recent news which mentions NVCR
Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?
June 08, 2025
From Benzinga
NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial
June 02, 2025
From Benzinga
1 Stock Down 35% This Year You'll Regret Not Buying on the Dip, According to Wall Street
May 28, 2025
Tickers
NVCR
From Motley Fool
From Benzinga
From Benzinga
Earnings Scheduled For April 24, 2025
April 24, 2025
From Benzinga
Prediction: Novocure (NVCR) Will Beat the Market. Here's Why
March 04, 2025
Tickers
NVCR
From Motley Fool
NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025
February 27, 2025
From Benzinga
NovoCure Q4 EPS Misses, Revenue Matches
February 27, 2025
From Motley Fool
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
From Benzinga
Deep Dive Into NovoCure Stock: Analyst Perspectives (7 Ratings)
January 14, 2025
Tickers
NVCR
From Benzinga
Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?
December 15, 2024
From Benzinga
SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
December 08, 2024
From Benzinga
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?
December 05, 2024
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 02, 2024
From Benzinga
Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates
December 02, 2024
From Benzinga
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
December 02, 2024
From Benzinga
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
December 02, 2024
From Benzinga
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
December 02, 2024
From Benzinga
Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
October 16, 2024
Tickers
NVCR
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.